TipRanks
Advertisement
Advertisement

PHMMF Stock Latest News

Pharma Mar Continues September Share Buyback on Madrid Exchange
Company AnnouncementsPharma Mar Continues September Share Buyback on Madrid Exchange
7d ago
Pharma Mar Wins U.K. Approval for Zepzelca Combo in Small-Cell Lung Cancer
PremiumCompany Announcements
Pharma Mar Wins U.K. Approval for Zepzelca Combo in Small-Cell Lung Cancer
14d ago
Pharma Mar Details August Share Buyback Transactions on Madrid Bourse
PremiumCompany Announcements
Pharma Mar Details August Share Buyback Transactions on Madrid Bourse
1M ago
Pharma Mar Flags Planned Loss of Zepzelca Second-Line SCLC Indication
PremiumCompany Announcements
Pharma Mar Flags Planned Loss of Zepzelca Second-Line SCLC Indication
2M ago
Pharma Mar Wins New Global Approvals for Zepzelca Lung Cancer Regimen
PremiumCompany Announcements
Pharma Mar Wins New Global Approvals for Zepzelca Lung Cancer Regimen
2M ago
Pharma Mar Steps Up July Share Buybacks on Madrid Market
PremiumCompany AnnouncementsPharma Mar Steps Up July Share Buybacks on Madrid Market
2M ago
Pharma Mar Board Endorses 2026 Half-Year Financial Report
Premium
Company Announcements
Pharma Mar Board Endorses 2026 Half-Year Financial Report
2M ago
PharmaMar Grows Recurring Revenue as EU Approval Boosts Zepzelca Outlook
Premium
Company Announcements
PharmaMar Grows Recurring Revenue as EU Approval Boosts Zepzelca Outlook
2M ago
Pharma Mar Board Approves 2026 Half-Year Financial Report
PremiumCompany Announcements
Pharma Mar Board Approves 2026 Half-Year Financial Report
2M ago
Pharma Mar Board Appointment Lapses, Governance Structure Unchanged
PremiumCompany Announcements
Pharma Mar Board Appointment Lapses, Governance Structure Unchanged
3M ago
Pharma Mar Halts Liquidity Contract to Launch Share Buyback Program
PremiumCompany Announcements
Pharma Mar Halts Liquidity Contract to Launch Share Buyback Program
3M ago
Pharma Mar Publishes Shareholder Presentation Ahead of 2026 AGM
PremiumCompany Announcements
Pharma Mar Publishes Shareholder Presentation Ahead of 2026 AGM
3M ago
Pharma Mar Shareholders Approve All Board Proposals at Ordinary Meeting
PremiumCompany AnnouncementsPharma Mar Shareholders Approve All Board Proposals at Ordinary Meeting
3M ago
Pharma Mar Declares €1.00 Tax-Free Dividend from Share Premium Reserve
Premium
Company Announcements
Pharma Mar Declares €1.00 Tax-Free Dividend from Share Premium Reserve
3M ago
Pharma Mar Overhauls Board and Committees in Governance Refresh
Premium
Company Announcements
Pharma Mar Overhauls Board and Committees in Governance Refresh
3M ago
Pharma Mar Launches €8 Million Share Buyback for Potential Corporate Deals
PremiumCompany Announcements
Pharma Mar Launches €8 Million Share Buyback for Potential Corporate Deals
3M ago
PharmaMar’s Partner Merck Seeks Priority Approval in Japan for Zepzelca as First-Line SCLC Maintenance
PremiumCompany Announcements
PharmaMar’s Partner Merck Seeks Priority Approval in Japan for Zepzelca as First-Line SCLC Maintenance
4M ago
Pharma Mar price target lowered to EUR 100 from EUR 120 at Chardan
PremiumThe Fly
Pharma Mar price target lowered to EUR 100 from EUR 120 at Chardan
4M ago
EU clears PharmaMar’s Zepzelca combo for first‑line maintenance in aggressive lung cancer
PremiumCompany Announcements
EU clears PharmaMar’s Zepzelca combo for first‑line maintenance in aggressive lung cancer
4M ago
Pharma Mar Calls 2026 Shareholders’ Meeting to Approve 2025 Results and Refresh Board
PremiumCompany AnnouncementsPharma Mar Calls 2026 Shareholders’ Meeting to Approve 2025 Results and Refresh Board
5M ago
PharmaMar Returns to Profit on Rising Zepzelca Sales and Strong Oncology Royalties
Premium
Company Announcements
PharmaMar Returns to Profit on Rising Zepzelca Sales and Strong Oncology Royalties
5M ago
Pharma Mar initiated with a Buy at BTIG
Premium
The Fly
Pharma Mar initiated with a Buy at BTIG
6M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >